The 6 minute walk (6MW) is usually used to evaluate exercise capacity in a variety of patient populations. We hypothesized that the 6MW would decline after chemotherapy and assessed the prognostic value of this test.
Division of Pulmonary Diseases, Department of Internal Medicine, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Quebec, Canada. gkasymja@pne.jgh.mcgill.ca